Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of TST001 in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TST001

Snippet

Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. | Conditions: Advanced Cancer | Phase 1, Phase 2 | Status: RECRUITING